Big Move For Brainstorm Cell Therapeutics Inc.

Wed, Mar 20, 2024 at 07:30 PM

Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ) shot up at $0.51, representing a gain of 42.5%. On Wed, Mar 20, 2024, BCLI:NASDAQ hit a New 2-Week High of $0.51. The stock appeared on our News Catalysts scanner on Wed, Mar 06, 2024 at 01:53 PM in the 'BIOTECH' category. From Wed, Mar 06, 2024, the stock recorded 40.00% Up Days and 27.27% Green Days

About Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ)

Brainstorm Cell Therapeutics Inc is a biotechnology company. The Company develops novel adult stem cell therapies for debilitating neurodegenerative disorders such as ALS, MS, and PD among others.

Top 10 Gainers:

Republic First Bancorp, Inc. (FRBK:NASDAQ), 280.95%
XTL Biopharmaceuticals Ltd. (XTLB:NASDAQ), 131.07%
SRAX, Inc. (SRAX:NASDAQ), 90%
Etao International Co. Ltd. (ETAO:NASDAQ), 88.81%
TruGolf Inc Cl A (TRUG:NASDAQ), 64.35%
Cazoo Group Ltd Class A (CZOO:NYSE), 63.85%
Anghami Inc. (ANGH:NASDAQ), 59%
Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ), 42.54%
AEye Inc. (LIDR:NASDAQ), 41.9%
Theriva Biologics Inc Com Par $.001 (TOVX:NYSEMKT), 39.95%